The Valley Desk

ArticleJAMA network openPublished

Cost-Effectiveness of Perioperative Enfortumab Vedotin and Pembrolizumab for Bladder Cancer

Read the publication ↗ Open access copy ↗

Regional connection

Verified An author affiliation on the Europe PMC record names Perelman School of Medicine, with University of Pennsylvania linked by the institution reference. Affiliation source

Publication record

Type
Article
Venue
JAMA network open
Published
Subject terms
Humans; Neoadjuvant Therapy; Cystectomy; Markov Chains; Quality-Adjusted Life Years; Aged; Cost-Benefit Analysis; Female; Male; Urinary Bladder Neoplasms; Antibodies, Monoclonal, Humanized; Antineoplastic Agents, Immunological
PubMed ID
42900471
PubMed Central ID
PMC13684492
Open access
Yes, open
Added to directory
Source checked

Report a correction or request removal